# WSFS Financial Corp: financial statements, quarterly

WSFS · Nasdaq · CIK 828944 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wsfs.md) · [Financials](/companies/wsfs/financials.md) · [Filings](/companies/wsfs/filings.md) · [Insiders](/companies/wsfs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wsfs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [68.5](/filings/0001628280-23-036743.md) | [79.1 d](/filings/0001628280-24-007987.md) | [86.3](/filings/0001628280-24-020601.md) | [90.8](/filings/0001628280-24-034342.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [22.9](/filings/0001628280-24-045632.md) | [29.4 d](/filings/0000828944-26-000006.md) | [21.2](/filings/0001628280-25-022978.md) | [21.3](/filings/0001628280-25-037054.md) | [21.1](/filings/0000828944-25-000013.md) | [20.2 d](/filings/0000828944-26-000006.md) | [21.1](/filings/0000828944-26-000015.md) | [23.3](/filings/0000828944-26-000028.md) | [24.4](/filings/0000828944-25-000013.md) | [24.5 d](/filings/0000828944-26-000006.md) | [27.6](/filings/0000828944-26-000015.md) | [26.8](/filings/0000828944-26-000028.md) |
| Net income | $m | [74.2](/filings/0001628280-24-045632.md) | [63.9 d](/filings/0000828944-26-000006.md) | [65.8](/filings/0001628280-25-022978.md) | [69.3](/filings/0001628280-25-037054.md) | [64.4](/filings/0000828944-25-000013.md) | [64.2 d](/filings/0000828944-26-000006.md) | [65.9](/filings/0000828944-26-000015.md) | [72.3](/filings/0000828944-26-000028.md) | [76.4](/filings/0000828944-25-000013.md) | [72.7 d](/filings/0000828944-26-000006.md) | [86.8](/filings/0000828944-26-000015.md) | [84.4](/filings/0000828944-26-000028.md) |
| Diluted EPS | $ per share | [1.22](/filings/0001628280-24-045632.md) | not reported | [1.09](/filings/0001628280-25-022978.md) | [1.16](/filings/0001628280-25-037054.md) | [1.08](/filings/0000828944-25-000013.md) | not reported | [1.12](/filings/0000828944-26-000015.md) | [1.27](/filings/0000828944-26-000028.md) | [1.37](/filings/0000828944-25-000013.md) | not reported | [1.64](/filings/0000828944-26-000015.md) | [1.63](/filings/0000828944-26-000028.md) |
| Basic EPS | $ per share | [1.22](/filings/0001628280-24-045632.md) | not reported | [1.09](/filings/0001628280-25-022978.md) | [1.16](/filings/0001628280-25-037054.md) | [1.09](/filings/0000828944-25-000013.md) | not reported | [1.13](/filings/0000828944-26-000015.md) | [1.28](/filings/0000828944-26-000028.md) | [1.37](/filings/0000828944-25-000013.md) | not reported | [1.64](/filings/0000828944-26-000015.md) | [1.63](/filings/0000828944-26-000028.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | [1.1](/filings/0001628280-25-008977.md) | not reported | not reported | not reported | [1.2](/filings/0000828944-26-000006.md) | not reported | not reported | not reported | [1.7](/filings/0000828944-26-000006.md) | not reported | not reported |
| Total assets | $bn | [20.0](/filings/0001628280-23-036743.md) | [20.6](/filings/0001628280-25-008977.md) | [20.6](/filings/0001628280-24-020601.md) | [20.7](/filings/0001628280-24-034342.md) | [20.9](/filings/0001628280-24-045632.md) | [20.8](/filings/0000828944-26-000006.md) | [20.5](/filings/0001628280-25-022978.md) | [20.8](/filings/0001628280-25-037054.md) | [20.8](/filings/0000828944-25-000013.md) | [21.3](/filings/0000828944-26-000028.md) | [22.1](/filings/0000828944-26-000015.md) | [22.7](/filings/0000828944-26-000028.md) |
| Total liabilities | $bn | [17.8](/filings/0001628280-23-036743.md) | [18.1](/filings/0001628280-25-008977.md) | [18.1](/filings/0001628280-24-020601.md) | [18.3](/filings/0001628280-24-034342.md) | [18.2](/filings/0001628280-24-045632.md) | [18.2](/filings/0000828944-26-000006.md) | [17.9](/filings/0001628280-25-022978.md) | [18.1](/filings/0001628280-25-037054.md) | [18.1](/filings/0000828944-25-000013.md) | [18.6](/filings/0000828944-26-000028.md) | [19.4](/filings/0000828944-26-000015.md) | [19.9](/filings/0000828944-26-000028.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.2](/filings/0001628280-23-036743.md) | [2.5](/filings/0001628280-25-008977.md) | [2.5](/filings/0001628280-24-020601.md) | [2.5](/filings/0001628280-24-034342.md) | [2.7](/filings/0001628280-24-045632.md) | [2.6](/filings/0000828944-26-000006.md) | [2.7](/filings/0001628280-25-022978.md) | [2.7](/filings/0001628280-25-037054.md) | [2.8](/filings/0000828944-25-000013.md) | [2.7](/filings/0000828944-26-000028.md) | [2.7](/filings/0000828944-26-000015.md) | [2.7](/filings/0000828944-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [165 d](/filings/0001628280-24-045632.md) | [(50.8) d](/filings/0000828944-26-000006.md) | [113](/filings/0001628280-25-022978.md) | [44.8 d](/filings/0001628280-25-037054.md) | [3.1 d](/filings/0000828944-25-000013.md) | [59.0 d](/filings/0000828944-26-000006.md) | [8.7](/filings/0000828944-26-000015.md) | [37.2 d](/filings/0000828944-26-000028.md) | [122 d](/filings/0000828944-25-000013.md) | [52.5 d](/filings/0000828944-26-000006.md) | [86.4](/filings/0000828944-26-000015.md) | [(12.7) d](/filings/0000828944-26-000028.md) |
| Capital expenditure | $m | [1.1 d](/filings/0001628280-24-045632.md) | [3.5 d](/filings/0000828944-26-000006.md) | [4.2](/filings/0001628280-25-022978.md) | [2.7 d](/filings/0001628280-25-037054.md) | [3.6 d](/filings/0000828944-25-000013.md) | [3.7 d](/filings/0000828944-26-000006.md) | [2.4](/filings/0000828944-26-000015.md) | [2.0 d](/filings/0000828944-26-000028.md) | [1.2 d](/filings/0000828944-25-000013.md) | [0.7 d](/filings/0000828944-26-000006.md) | [0.9](/filings/0000828944-26-000015.md) | [1.7 d](/filings/0000828944-26-000028.md) |
| Dividends paid | $m | [9.2 d](/filings/0001628280-24-045632.md) | [9.1 d](/filings/0000828944-26-000006.md) | [9.1](/filings/0001628280-25-022978.md) | [9.0 d](/filings/0001628280-25-037054.md) | [8.9 d](/filings/0000828944-25-000013.md) | [8.8 d](/filings/0000828944-26-000006.md) | [8.8](/filings/0000828944-26-000015.md) | [9.6 d](/filings/0000828944-26-000028.md) | [9.5 d](/filings/0000828944-25-000013.md) | [9.3 d](/filings/0000828944-26-000006.md) | [9.0](/filings/0000828944-26-000015.md) | [10.4 d](/filings/0000828944-26-000028.md) |
| Share repurchases | $m | [15.8 d](/filings/0001628280-24-045632.md) | [10.0 d](/filings/0000828944-26-000006.md) | [21.0](/filings/0001628280-25-022978.md) | [40.2 d](/filings/0001628280-25-037054.md) | [14.0 d](/filings/0000828944-25-000013.md) | [21.2 d](/filings/0000828944-26-000006.md) | [54.3](/filings/0000828944-26-000015.md) | [78.4 d](/filings/0000828944-26-000028.md) | [47.2 d](/filings/0000828944-25-000013.md) | [110 d](/filings/0000828944-26-000006.md) | [85.8](/filings/0000828944-26-000015.md) | [66.8 d](/filings/0000828944-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [63.2](/filings/0001628280-23-036743.md) | [61.7](/filings/0001628280-24-020601.md) | [61.4](/filings/0001628280-24-034342.md) | [61.0](/filings/0001628280-24-045632.md) | [60.5](/filings/0001628280-25-022978.md) | [60.0](/filings/0001628280-25-037054.md) | [59.4](/filings/0000828944-25-000013.md) | [58.7](/filings/0000828944-26-000015.md) | [56.9](/filings/0000828944-26-000028.md) | [56.0](/filings/0000828944-25-000013.md) | [53.0](/filings/0000828944-26-000015.md) | [51.9](/filings/0000828944-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 51,090,605 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0000828944-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.